Literature DB >> 34602622

Stability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable Solutions.

M Mihaela Friciu1, Anaëlle Monfort2, Pierre-André Dubé3, Grégoire Leclair4.   

Abstract

BACKGROUND: N-Acetylcysteine (NAC) administered by the IV route is the current treatment of choice for acetaminophen overdose. However, the protocol approved by health authorities in most countries has a complex dosing regimen, which leads to dosage errors in one-third of cases. Therefore, the Canadian Antidote Guide in Acute Care Toxicology and individual poison centres have begun to recommend a simplified regimen using continuous IV infusion. Unfortunately, no study has demonstrated the stability of IV solutions of NAC at concentrations above 30 mg/mL or in solutions other than 5% dextrose.
OBJECTIVE: To evaluate the stability of solutions of NAC 60 mg/mL in 0.9% sodium chloride, 0.45% sodium chloride, or 5% dextrose, stored for up to 72 hours in polyvinyl chloride (PVC) bags at 25°C.
METHODS: Solutions of the desired concentration were prepared from a commercial solution of NAC 200 mg/mL, with dilution in 0.9% sodium chloride, 0.45% sodium chloride, or 5% dextrose, and were then stored at room temperature in PVC bags for up to 72 hours. At predetermined time points (0, 16, 24, 40, 48 and 72 h), samples were collected and analyzed using a stability-indicating high-performance liquid chromatography method. A solution was considered stable if it maintained at least 90.0% of its initial concentration. Particulate matter count was also evaluated to confirm chemical stability. Finally, organoleptic properties, such as odour and colour, were evaluated to assess the stability of the solutions.
RESULTS: All solutions maintained at least 98.7% of their initial concentration. No obvious changes in odour or colour were observed. Moreover, particle counts remained acceptable throughout the study, according to the criteria specified in United States Pharmacopeia (USP) General Chapter <788>.
CONCLUSIONS: NAC 60 mg/mL, diluted in 0.9% sodium chloride, 0.45% sodium chloride, or 5% dextrose and stored in PVC bags at 25°C, was chemically and physically stable for a period of at least 72 hours. 2021 Canadian Society of Hospital Pharmacists. All content in the Canadian Journal of Hospital Pharmacy is copyrighted by the Canadian Society of Hospital Pharmacy. In submitting their manuscripts, the authors transfer, assign, and otherwise convey all copyright ownership to CSHP.

Entities:  

Keywords:  N-acetylcysteine; acetaminophen overdose; antidote; stability

Year:  2021        PMID: 34602622      PMCID: PMC8463017          DOI: 10.4212/cjhp.v74i4.3082

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  13 in total

1.  Stability and microbiology of inhalant N-acetylcysteine used as an intravenous solution for the treatment of acetaminophen poisoning.

Authors:  William H Dribben; Stephanie M Porto; Brian K Jeffords
Journal:  Ann Emerg Med       Date:  2003-07       Impact factor: 5.721

2.  Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus.

Authors:  Alexander L Fohl; Cary E Johnson; M Petrea Cober
Journal:  Am J Health Syst Pharm       Date:  2011-01-01       Impact factor: 2.637

3.  Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions.

Authors:  Anselm Wong; Andis Graudins
Journal:  Clin Toxicol (Phila)       Date:  2015-11-23       Impact factor: 4.467

Review 4.  Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice.

Authors:  Manu L N G Malbrain; Paul E Marik; Ine Witters; Colin Cordemans; Andrew W Kirkpatrick; Derek J Roberts; Niels Van Regenmortel
Journal:  Anaesthesiol Intensive Ther       Date:  2014 Nov-Dec

5.  Association Between Fluid Balance and Outcomes in Critically Ill Children: A Systematic Review and Meta-analysis.

Authors:  Rashid Alobaidi; Catherine Morgan; Rajit K Basu; Erin Stenson; Robin Featherstone; Sumit R Majumdar; Sean M Bagshaw
Journal:  JAMA Pediatr       Date:  2018-03-01       Impact factor: 16.193

6.  Stability of acetylcysteine solution repackaged in oral syringes and associated cost savings.

Authors:  Tyree H Kiser; Alan R Oldland; Douglas N Fish
Journal:  Am J Health Syst Pharm       Date:  2007-04-01       Impact factor: 2.637

7.  Fewer adverse effects with a modified two-bag acetylcysteine protocol in paracetamol overdose.

Authors:  Richard McNulty; Jia Min Elizabeth Lim; Pramod Chandru; Naren Gunja
Journal:  Clin Toxicol (Phila)       Date:  2017-12-08       Impact factor: 4.467

8.  N-acetylcysteine regimens for paracetamol overdose: Time for a change?

Authors:  Anselm Wong; Andis Graudins
Journal:  Emerg Med Australas       Date:  2016-05-18       Impact factor: 2.151

9.  Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose.

Authors:  Bryan D Hayes; Wendy Klein-Schwartz; Suzanne Doyon
Journal:  Ann Pharmacother       Date:  2008-04-29       Impact factor: 3.154

Review 10.  A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing.

Authors:  Joseph I Boullata; Karen Gilbert; Gordon Sacks; Reginald J Labossiere; Cathy Crill; Praveen Goday; Vanessa J Kumpf; Todd W Mattox; Steve Plogsted; Beverly Holcombe
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-02-14       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.